Cytomegalovirus Infection and Lung Function in Liver Transplant Recipients: A Nationwide Cohort Study
Authors:
- Moises Alberto Suarez‐ZdunekMSMoises Alberto Suarez‐Zdunek
- Hans‐Christian PommergaardHPHans‐Christian Pommergaard
- Nicoline S. ArentoftNANicoline S. Arentoft
- Nikolai S. KirkbyNKNikolai S. Kirkby
- Niels K. M. AagaardNANiels K. M. Aagaard
- Annette D. FiallaAFAnnette D. Fialla
- Jesper B. HansenJHJesper B. Hansen
- Michael PerchMPMichael Perch
- Paul S. KrohnPKPaul S. Krohn
- Andreas D. KnudsenAKAndreas D. Knudsen
- Susanne D. NielsenSNSusanne D. Nielsen
Open Access
Abstract
Impaired lung function is more common among liver transplant recipients than the general population, but the pathogenesis is unknown. We investigated whether prior CMV infections are associated with impaired lung function in liver transplant recipients. We invited adult liver transplant recipients from The Danish Comorbidity in Liver Transplant Recipients study (DACOLT) for spirometry and collected data from systematic CMV screening for serostatus and DNAemia. Using linear and logistic regressions adjusted for age, sex, cumulative smoking, and use of inhalation medication, we assessed if prior CMV infections were associated with airflow limitation (FEV 1 /FVC < 0.7 and FEV 1 < 80% of expected) and FEV 1 . Of all eligible liver transplant recipients in Denmark, DACOLT included 600 (79%), and 356 fulfilled the substudy‐specific inclusion criteria. In adjusted models, pretransplant CMV seropositivity was not associated with either airflow limitation (aOR 2.18 [95% CI: 0.71–6.62]) or lower FEV 1 (adjusted β [a β ] = −60 [95% CI: −210 to 80] mL). The same applied to associations between prior CMV DNAemia and airflow limitation (aOR 0.91 [95% CI: 0.35–2.35]) as well as FEV 1 (a β = 30 [95% CI: −120 to 180] mL). This suggests limited clinical impact of CMV infection on posttransplant lung function in liver transplant recipients.Keywords
Funding Information
- Svend Andersen Fonden
- Kirsten og Freddy Johansens Fond
- Arvid Nilssons Fond
- Danmarks Frie Forskningsfond (10.46540/3101‐00030B)
- Rigshospitalet
- Novo Nordisk Fonden (12495)
This publication has 26 references indexed in Scilit:
- Cytomegalovirus infection and coronary artery disease in liver transplant recipients: Nationwide study using protocolized cardiac computed tomographyInternational Journal of Infectious Diseases, 2026
- High cytomegalovirus antibody concentrations and lower lung function in persons with HIV who smokeAnnals of the American Thoracic Society, 2026
- Frequency of viral monitoring to detect cytomegalovirus infection and prevent disease in solid organ transplant recipients: An international, multicenter cohort studyAmerican Journal of Transplantation, 2026
- Molecular mechanisms and targets underlying immune evasion by human cytomegalovirusJournal of Microbiology, Immunology and Infection, 2025
- Liver TransplantationNew England Journal of Medicine, 2023
- Cytomegalovirus-Specific Immunoglobulin G Is Associated With Chronic Lung Disease in Children and Adolescents from Sub-Saharan Africa Living With Perinatal Human Immunodeficiency VirusClinical Infectious Diseases, 2020
- Clinical evaluation of Roche COBAS® AmpliPrep/COBAS® TaqMan® CMV test using nonplasma samplesJournal of Medical Virology, 2018
- Evaluation of the new LIAISON ® CMV IgG, IgM and IgG Avidity II assaysJournal of Clinical Virology, 2015
- Risk factors for cytomegalovirus reactivation after liver transplantation: Can pre‐transplant cytomegalovirus antibody titers predict outcome?Liver Transplantation, 2015
- Cytomegalovirus Antibody Levels, Inflammation, and Mortality Among Elderly Latinos Over 9 Years of Follow-upAmerican Journal of Epidemiology, 2010